Literature DB >> 28826919

Surgical treatment for spinal dural arteriovenous fistulas: Outcome, complications and prognostic factors.

Jakub Wojciechowski1, Przemysław Kunert2, Arkadiusz Nowak1, Tomasz Dziedzic1, Tomasz Czernicki1, Katarzyna Wójtowicz1, Kamil Leśniewski1, Andrzej Marchel1.   

Abstract

BACKGROUND AND
PURPOSE: Spinal dural arteriovenous fistulas (SDAVFs) are rare, acquired pathology and they inevitably lead to severe disability if untreated. The aim of this study is to present the outcome and complications, and to find factors that may affect the outcome after surgical treatment.
METHODS: Seventeen consecutive patients (men - 14, women - 3, age: 41-79) were retrospectively analyzed. The patients presented with paraparesis (88%), bladder symptoms (71%) and/or sensory disturbances (65%). The fistula was found in the upper thoracic spine in 2 cases, in the lower thoracic (T7-Th12) in 11 cases, and in the lumbar spine in 4 cases. Microsurgical shunt interruption was performed in all, followed by epidural arteries coagulation in 12 cases.
RESULTS: In the long term, improvement or achievement of a good stable condition was observed in 13 patients (76%), and no patient deteriorated. All 5 paraplegic patients improved by at least 1 grade in MCS. Satisfactory results (modified McCormick Scale grades I-II) were found in 10 patients (59%), and 15(88%) were independent. Postoperative complications occurred in 4 patients (24%), two of them (12%) required revision surgery for epidural hematoma. The success rate was 94%; one patient required revision surgery for recurrent SDAVF. Better neurological condition on admission (p=0.0098) and age >60 years (p=0.0498) were the factors associated with satisfactory outcome.
CONCLUSIONS: Microsurgical closing of a SDAVF brings good and stable results over time. Aggressive treatment should be attempted even in cases of total loss of spinal cord function. Neurological condition before surgery and age may influence the outcome.
Copyright © 2017 Polish Neurological Society. Published by Elsevier Urban & Partner Sp. z o.o. All rights reserved.

Entities:  

Keywords:  Complications; Outcome; Spinal dural arteriovenous fistula; Spinal vascular malformation; Surgery

Mesh:

Year:  2017        PMID: 28826919     DOI: 10.1016/j.pjnns.2017.07.001

Source DB:  PubMed          Journal:  Neurol Neurochir Pol        ISSN: 0028-3843            Impact factor:   1.621


  6 in total

Review 1.  Enhanced recovery after surgery in intramedullary and extramedullary spinal cord lesions: perioperative considerations and recommendations.

Authors:  Sauson Soldozy; Parantap Patel; Mazin Elsarrag; Pedro Norat; Daniel M Raper; Jennifer D Sokolowski; Kaan Yağmurlu; Min S Park; Petr Tvrdik; M Yashar S Kalani
Journal:  Spinal Cord       Date:  2019-07-29       Impact factor: 2.772

Review 2.  Sphenoid dural arteriovenous fistulas.

Authors:  Michael George Zaki Ghali
Journal:  Neurosurg Rev       Date:  2019-12-07       Impact factor: 3.042

3.  Coincidence of Tethered Cord, Filum Terminale Lipoma, and Sacral Dural Arteriovenous Fistula: Report of Two Cases and a Literature Review.

Authors:  Łukasz Przepiórka; Przemysław Kunert; Paulina Juszyńska; Michał Zawadzki; Bogdan Ciszek; Mariusz Głowacki; Andrzej Marchel
Journal:  Front Neurol       Date:  2018-09-27       Impact factor: 4.003

4.  Imaging characteristics, misdiagnosis and microsurgical outcomes of patients with spinal dural arteriovenous fistula: a retrospective study of 32 patients.

Authors:  Han-Bing Zhang; Xiao-Lei Zhai; Lu Li; De-Shen Wu; Guang-Liang Zhuang; Qi-Wu Xu; Hui Guo; Jie Wang
Journal:  Ann Transl Med       Date:  2022-08

5.  Spinal dural arteriovenous fistula: A rare but treatable disease that should not be missed by orthopedic surgeons.

Authors:  Baohui Yang; Teng Lu; Xijing He; Haopeng Li
Journal:  Front Neurol       Date:  2022-09-20       Impact factor: 4.086

6.  Spinal dural arteriovenous fistula 8 years after lumbar discectomy surgery: A case report and review of literature.

Authors:  Yang Ouyang; Yang Qu; Rong-Peng Dong; Ming-Yang Kang; Tong Yu; Xue-Liang Cheng; Jian-Wu Zhao
Journal:  World J Clin Cases       Date:  2021-07-16       Impact factor: 1.337

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.